The End Brain Cancer Initiative is hosting an online roundtable discussion for patients and care partners in the Primary Central Nervous System Lymphoma (PCNSL) community on April 11, 2025 from 11AM to 12:30PM Pacific Time. The PCNSL Online Roundtable will help further resources and education provided to this patient population by doing a deep dive into the results of their recent PCNSL patient and care partner survey. The roundtable, sponsored by Ono Pharmaceutical, will be moderated by Dellann Elliott Mydland, President and CEO of the End Brain Cancer Initiative. Patients and care partners interested in participating in this discussion should fill out the interest form on EBCI's website before March 31, 2025. Qualifying participants will be compensated $75 for their time. https://lnkd.in/gBhfphFu
The EndBrainCancer Initiative - (The Chris Elliott Fund)
非盈利组织
Redmond，WA 641 位关注者
Connecting brain tumor patients to specialists, treatments & trials. Support patients & loved ones by donating now. ??
关于我们
Guided by our mission to end brain cancer by providing immediate patient access to specialists, advanced treatments, and comprehensive support programs, The End Brain Cancer Initiative is committed to finding a cure and bringing hope to the lives of patients and their families. For more than a decade, The End Brain Cancer Initiative has distinctly served as one of the nation’s premier resources dedicated to providing brain tumor patients with crucial patient services and immediate access to advanced treatments and comprehensive support programs. Through our education and awareness events and our call center and advocacy hotline, we are building a network of doctors, patients, survivors, caregivers, loved ones and friends who are passionately dedicated to winning the fight to end brain cancer.
- 网站
-
https://endbraincancer.org
The EndBrainCancer Initiative - (The Chris Elliott Fund)的外部链接
- 所属行业
- 非盈利组织
- 规模
- 2-10 人
- 总部
- Redmond，WA
- 类型
- 非营利机构
- 创立
- 2002
- 领域
- Brain tumor patient, caregiver & family information, advocacy, and support.
地点
-
主要
获取路线
14959 NE 95th St.
US，WA，Redmond，98052
The EndBrainCancer Initiative - (The Chris Elliott Fund)员工
-
Chris Conley
I ?? Biotech - Startup Advisor - Company Builder - Consultant
-
Susan Kellner (Alfred)
Digital Marketer Extraordinaire. Owner/Manager at CoeurCryo, Whim Social, SK Brokers and Volunteer Digital Marketer for the End Brain Cancer…
-
Lisa (Steinberg) Lenrow, MBA, PPALS
Patient Advocate and Marketing Strategist
-
Shawn Drennan
Treasurer and Board Member
动态
-
Ependymoma Explained: Navigating Diagnosis, Treatment, and Survivorship Do you or your loved one have an ependymoma? Join this webinar, presented in partnership with the Pediatric Brain Tumor Foundation, to get the breakdown of what to expect from diagnosis to recovery, explore treatment options and advancements, and get practical tips on how to partner with your medical team to make decisions and manage your care from diagnosis through survivorship. This webinar will have Spanish subtitles available. Este seminario de web tendrá subtítulos en espa?ol. Thursday, March 20th 1 PM CT | Free
-
-
The End Brain Cancer Initiative is hosting an online roundtable discussion for patients and care partners in the Primary Central Nervous System Lymphoma (PCNSL) community on April 11, 2025 from 11AM to 12:30PM Pacific Time. The PCNSL Online Roundtable will help further resources and education provided to this patient population by doing a deep dive into the results of their recent PCNSL patient and care partner survey. The roundtable, sponsored by Ono Pharmaceutical, will be moderated by Dellann Elliott Mydland, President and CEO of the End Brain Cancer Initiative. Patients and care partners interested in participating in this discussion should fill out the interest form on EBCI's website before March 31, 2025. Qualifying participants will be compensated $75 for their time. https://lnkd.in/gBhfphFu
-
-
The End Brain Cancer Initiative is hosting an online roundtable discussion for patients and care partners in the Primary Central Nervous System Lymphoma (PCNSL) community on April 11, 2025 from 11AM to 12:30PM Pacific Time. The PCNSL Online Roundtable will help further resources and education provided to this patient population by doing a deep dive into the results of their recent PCNSL patient and care partner survey. The roundtable, sponsored by Ono Pharmaceutical, will be moderated by Dellann Elliott Mydland, President and CEO of the End Brain Cancer Initiative. Patients and care partners interested in participating in this discussion should fill out the interest form on EBCI's website before March 31, 2025. Qualifying participants will be compensated $75 for their time.
-
-
How much do you know about cancer prevention? While cancer can affect anyone, anywhere, there are still steps you can take to proactively and significantly reduce your risk. Some of them, you might already know. But some might surprise you! Conquer Cancer has prepared this quiz to test your knowledge: https://lnkd.in/gZgVsNzT Enjoy!
-
-
CISCRP is hosting a virtual patient advisory board to gather insights from individuals living with Glioblastoma and their caregivers. By participating, you help shape future clinical trials to better meet patient needs. It's online via Zoom and take 2 sessions (2h each). ?? As a thank you for your time, CISCRP will provide an honorarium to those who are eligible and participate. ?? Interested in participating or learning more? Contact Kaitlin Gossart at [email protected] or call 617-725-2750 ext. 413. Join us in making a difference! ?? #Glioblastoma #PatientAdvocacy #ClinicalResearch #CISCRP
-
-
The End Brain Cancer Initiative is hosting an online roundtable discussion for patients and care partners in the Primary Central Nervous System Lymphoma (PCNSL) community on April 11, 2025 from 11AM to 12:30PM Pacific Time. The PCNSL Online Roundtable will help further resources and education provided to this patient population by doing a deep dive into the results of their recent PCNSL patient and care partner survey. The roundtable, sponsored by Ono Pharmaceutical, will be moderated by Dellann Elliott Mydland, President and CEO of the End Brain Cancer Initiative. Patients and care partners interested in participating in this discussion should fill out the interest form on EBCI's website before March 31, 2025. Qualifying participants will be compensated $75 for their time.
-
-
Opportunity to make your voice heard - and earn a $25 compensation for your time! The End Brain Cancer Initiative is working with Ono Pharma to collect the thoughts of patients and care partners in order to improve and increase available resources for the PCNSL community, and how you want to receive this info. You can fill out the interest form, and learn more about PCNSL at https://lnkd.in/gBhfphFu
-
-
Our Board Member and Scientific & Advisory chair spent the evening engaging with a group of female neuro-oncologists after Day #1 at the 6th GBM DRUG DEV SUMMIT in Boston. #GBMSummit2025 #neurooncology #fightglioblastoma
-
-
Our Board Member and Scientific & Advisory chair spent the evening engaging with a group of female neuro-oncologists after Day #1 at the 6th GBM DRUG DEV SUMMIT in Boston. #GBMSummit2025 #neurooncology #fightglioblastoma
-